Literature DB >> 10830410

Early detection of probable idiopathic Parkinson's disease: I. Development of a diagnostic test battery.

E B Montgomery1, W C Koller, T J LaMantia, M C Newman, E Swanson-Hyland, A W Kaszniak, K Lyons.   

Abstract

We developed a test battery as an inexpensive and objective aid for the early diagnosis of idiopathic Parkinson's disease (iPD) and its differential diagnoses. The test battery incorporates tests of motor function, olfaction, and mood. In the motor task, a wrist flexion-and-extension task to different targets, movement velocities were recorded. Olfaction was tested with the University of Pennsylvania Smell Identification Test. Mood was assessed with the Beck Depression Inventory. An initial regression model was developed from the results of 19 normal control subjects and 18 patients with early, mild, probable iPD. Prospective application to an independent validation set of 122 normal control subjects and 103 patients resulted in an 88% specificity rate and 69% sensitivity rate, with an area under the Receiver Operator Characteristic curve of 0.87.

Entities:  

Mesh:

Year:  2000        PMID: 10830410

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  9 in total

Review 1.  Neuroproteomics as a promising tool in Parkinson's disease research.

Authors:  Ilse S Pienaar; William M U Daniels; Jürgen Götz
Journal:  J Neural Transm (Vienna)       Date:  2008-06-04       Impact factor: 3.575

2.  Application of modified regression techniques to a quantitative assessment for the motor signs of Parkinson's disease.

Authors:  Bambi R Brewer; Sujata Pradhan; George Carvell; Anthony Delitto
Journal:  IEEE Trans Neural Syst Rehabil Eng       Date:  2009-10-30       Impact factor: 3.802

3.  Variability of EMG patterns: a potential neurophysiological marker of Parkinson's disease?

Authors:  Julie A Robichaud; Kerstin D Pfann; Sue Leurgans; David E Vaillancourt; Cynthia L Comella; Daniel M Corcos
Journal:  Clin Neurophysiol       Date:  2008-12-11       Impact factor: 3.708

Review 4.  Biomarkers for evaluation of clinical efficacy of multipotential neuroprotective drugs for Alzheimer's and Parkinson's diseases.

Authors:  Ilan Halperin; Micaela Morelli; Amos D Korczyn; Moussa B H Youdim; Silvia A Mandel
Journal:  Neurotherapeutics       Date:  2009-01       Impact factor: 7.620

5.  Biomarkers for prediction and targeted prevention of Alzheimer's and Parkinson's diseases: evaluation of drug clinical efficacy.

Authors:  Silvia A Mandel; Micaela Morelli; Ilan Halperin; Amos D Korczyn
Journal:  EPMA J       Date:  2010-06-29       Impact factor: 6.543

Review 6.  Diagnostic Criteria for Parkinson's Disease: From James Parkinson to the Concept of Prodromal Disease.

Authors:  Luca Marsili; Giovanni Rizzo; Carlo Colosimo
Journal:  Front Neurol       Date:  2018-03-23       Impact factor: 4.003

7.  Age Related Prevalence of Mild Cognitive Impairment in Type 2 Diabetes Mellitus Patients in the Indian Population and Association of Serum Lipids With Cognitive Dysfunction.

Authors:  Arpita Chakraborty; Sumukha Hegde; Samir K Praharaj; Krishnananda Prabhu; Chhaya Patole; Ashok K Shetty; Shreemathi S Mayya; Raviraj V Acharya; H Manjunath Hande; M Mukhyaprana Prabhu; Dinesh Upadhya
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-31       Impact factor: 5.555

8.  Screening for Parkinson's disease with response time batteries: a pilot study.

Authors:  Andrew M Johnson; Philip A Vernon; Quincy J Almeida; Linda L Grantier; Rene Singarayer; Mandar S Jog
Journal:  BMC Med Inform Decis Mak       Date:  2004-09-13       Impact factor: 2.796

9.  A novel approach to rapidly prevent age-related cognitive decline.

Authors:  Paul A Adlard; Amelia Sedjahtera; Lydia Gunawan; Lisa Bray; Dominic Hare; Jessica Lear; Philip Doble; Ashley I Bush; David I Finkelstein; Robert A Cherny
Journal:  Aging Cell       Date:  2013-12-04       Impact factor: 9.304

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.